India has more than 50 million cases diagnosed with diabetes, and ranks among the top three nations with high number of diabetes population. Many effective therapies are in use for the treatment of diabetes.
Empagliflozin is one such recently discovered molecule which is recommended for the efficacious control of diabetes and associated cardiovascular and renal risks. This survey intends to understand your inputs about the benefits and use of empagliflozin for effective glycemic control in diabetic patients.
